MX352546B - Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo. - Google Patents
Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo.Info
- Publication number
- MX352546B MX352546B MX2014001784A MX2014001784A MX352546B MX 352546 B MX352546 B MX 352546B MX 2014001784 A MX2014001784 A MX 2014001784A MX 2014001784 A MX2014001784 A MX 2014001784A MX 352546 B MX352546 B MX 352546B
- Authority
- MX
- Mexico
- Prior art keywords
- thrombi
- imaging
- iiia
- binding
- compounds
- Prior art date
Links
- 238000003384 imaging method Methods 0.000 title abstract 4
- 102000003886 Glycoproteins Human genes 0.000 title abstract 2
- 108090000288 Glycoproteins Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000002600 positron emission tomography Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a compuestos novedosos que contienen flúor, métodos para su preparación, los intermediarios de la síntesis, su uso como agentes de diagnóstico, especialmente para la formación de imágenes de trombos. La invención se refiere a agentes de tomografía de emisión de positrones (PET) y reactivos precursores asociados, y métodos para producir tales agentes radioetiquetados para la formación de imágenes de trombos en un cuerpo de mamífero. Más particularmente, la invención se refiere a antagonistas de glicoproteina IIb/IIIa de unión específica, de alta afinidad, sin péptidos, pequeños para la formación de imágenes de trombos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11075195 | 2011-08-17 | ||
| PCT/EP2012/003583 WO2013023795A1 (en) | 2011-08-17 | 2012-08-17 | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014001784A MX2014001784A (es) | 2014-05-01 |
| MX352546B true MX352546B (es) | 2017-11-29 |
Family
ID=46724333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014001784A MX352546B (es) | 2011-08-17 | 2012-08-17 | Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9345793B2 (es) |
| EP (1) | EP2744802B1 (es) |
| JP (2) | JP6243335B2 (es) |
| KR (1) | KR101948362B1 (es) |
| CN (1) | CN103906743B (es) |
| AU (1) | AU2012297137B2 (es) |
| BR (1) | BR112014003366B1 (es) |
| CA (1) | CA2845477C (es) |
| DK (1) | DK2744802T3 (es) |
| ES (1) | ES2621379T3 (es) |
| HR (1) | HRP20170464T1 (es) |
| IL (1) | IL230854A (es) |
| MX (1) | MX352546B (es) |
| MY (1) | MY174617A (es) |
| NZ (1) | NZ620635A (es) |
| PL (1) | PL2744802T3 (es) |
| PT (1) | PT2744802T (es) |
| RU (1) | RU2597425C2 (es) |
| SG (1) | SG2014011225A (es) |
| SI (1) | SI2744802T1 (es) |
| WO (1) | WO2013023795A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3091326B2 (ja) | 1992-08-25 | 2000-09-25 | 松下電工株式会社 | 成膜方法 |
| MY174617A (en) * | 2011-08-17 | 2020-05-01 | Life Molecular Imaging Sa | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
| KR101493571B1 (ko) * | 2012-12-24 | 2015-02-13 | (주)엘지하우시스 | 저방사 투명 적층체 및 이를 포함하는 건축 자재 |
| JP6099045B2 (ja) * | 2013-04-30 | 2017-03-22 | 国立大学法人京都大学 | トリアゾロピリミジン誘導体化合物 |
| JP5847140B2 (ja) * | 2013-08-29 | 2016-01-20 | 国立大学法人東北大学 | 慢性血栓塞栓性肺高血圧症の検査方法 |
| CN105960403A (zh) * | 2014-02-11 | 2016-09-21 | 拜耳制药股份公司 | 用于结合血小板特异性糖蛋白iib/iiia的金属螯合物 |
| JP2015193545A (ja) * | 2014-03-31 | 2015-11-05 | 国立大学法人京都大学 | ２−（３−ピリジニル）−１ｈ−ベンズイミダゾール誘導体化合物、これを含む放射性医薬 |
| CN105699563A (zh) * | 2016-04-25 | 2016-06-22 | 广西壮族自治区梧州食品药品检验所 | 双波长高效液相色谱检测血栓通的方法 |
| CA3046489A1 (en) | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
| CA3045931A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| US20230033021A1 (en) | 2018-06-20 | 2023-02-02 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| CN116726361A (zh) | 2018-11-19 | 2023-09-12 | 比奥拉治疗股份有限公司 | 用生物治疗剂治疗疾病的方法和装置 |
| WO2021119482A1 (en) | 2019-12-13 | 2021-06-17 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| KR102548998B1 (ko) | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
| WO2022192545A1 (en) * | 2021-03-10 | 2022-09-15 | Dice Molecules Sv, Inc. | Alpha v beta 6 and alpha v beta 1 integrin inhibitors and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239846A (en) | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
| US5645815A (en) | 1991-02-08 | 1997-07-08 | Diatide, Inc. | Radiolabled compounds for thrombus imaging |
| US5830856A (en) | 1991-02-08 | 1998-11-03 | Diatide, Inc. | Radiolabeled compounds for thrombus imaging |
| US5508020A (en) | 1992-06-05 | 1996-04-16 | Diatech, Inc. | Technetium-99M labeled peptides for imaging |
| RU2161155C2 (ru) | 1993-09-22 | 2000-12-27 | Фудзисава Фармасьютикал Ко., Лтд | Производные n-(3-пиперидинилкарбонил)-бета-аланина в качестве антагонистов фактора активации тромбоцитов (фат), способ получения, фармацевтическая композиция и способ лечения |
| CA2215106A1 (en) | 1995-03-17 | 1996-09-26 | Fujisawa Pharmaceutical Co., Ltd. | N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors |
| DE19540700A1 (de) | 1995-11-02 | 1997-05-07 | Daniels & Korff Gmbh | Oberhemd mit Kragen |
| WO1997033869A1 (en) | 1996-03-13 | 1997-09-18 | Fujisawa Pharmaceutical Co., Ltd. | N-[(r)-1-{3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
| WO1997041102A1 (en) | 1996-05-01 | 1997-11-06 | Ortho Pharmaceutical Corporation | Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| US6066651A (en) | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
| US6028056A (en) | 1998-02-06 | 2000-02-22 | Diatide, Inc. | Pharmaceutical compositions for imaging and treating thrombi |
| UA67832C2 (uk) | 1999-03-22 | 2004-07-15 | Орто-Макнейл Фармацевтикал, Інк. | СПОСІБ ОТРИМАННЯ [S-(R<sup>*</sup>,S<sup>*</sup>)]-<font face="Symbol">b</font>-[[[1-[1-ОКСО-3-(4-ПІПЕРИДИНІЛ)ПРОПІЛ]-3-ПІПЕРИДИНІЛ]КАРБОНІЛ]АМІНО]-3-ПІРИДИНПРОПАНОВОЇ КИСЛОТИ ТА ЇЇ ПОХІДНИХ |
| WO2005079863A1 (ja) * | 2004-02-25 | 2005-09-01 | Astellas Pharma Inc. | 血栓造影剤 |
| CA2729635A1 (en) * | 2008-07-03 | 2010-01-07 | Ananth Srinivasan | Compounds and processes for production of radiopharmaceuticals |
| UY32158A (es) | 2008-10-03 | 2010-04-30 | Astrazeneca Ab | Derivados heterociclicos y metodos de uso de los mismos |
| MY174617A (en) * | 2011-08-17 | 2020-05-01 | Life Molecular Imaging Sa | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
-
2012
- 2012-08-17 MY MYPI2014000391A patent/MY174617A/en unknown
- 2012-08-17 KR KR1020147006644A patent/KR101948362B1/ko active Active
- 2012-08-17 JP JP2014525352A patent/JP6243335B2/ja active Active
- 2012-08-17 AU AU2012297137A patent/AU2012297137B2/en active Active
- 2012-08-17 HR HRP20170464TT patent/HRP20170464T1/hr unknown
- 2012-08-17 RU RU2014109853/04A patent/RU2597425C2/ru active
- 2012-08-17 WO PCT/EP2012/003583 patent/WO2013023795A1/en not_active Ceased
- 2012-08-17 PT PT127503316T patent/PT2744802T/pt unknown
- 2012-08-17 PL PL12750331T patent/PL2744802T3/pl unknown
- 2012-08-17 BR BR112014003366-8A patent/BR112014003366B1/pt active IP Right Grant
- 2012-08-17 CA CA2845477A patent/CA2845477C/en active Active
- 2012-08-17 CN CN201280050196.4A patent/CN103906743B/zh active Active
- 2012-08-17 EP EP12750331.6A patent/EP2744802B1/en active Active
- 2012-08-17 SI SI201230874A patent/SI2744802T1/sl unknown
- 2012-08-17 DK DK12750331.6T patent/DK2744802T3/en active
- 2012-08-17 ES ES12750331.6T patent/ES2621379T3/es active Active
- 2012-08-17 NZ NZ620635A patent/NZ620635A/en not_active IP Right Cessation
- 2012-08-17 SG SG2014011225A patent/SG2014011225A/en unknown
- 2012-08-17 MX MX2014001784A patent/MX352546B/es active IP Right Grant
- 2012-08-17 US US14/239,065 patent/US9345793B2/en active Active
-
2014
- 2014-02-06 IL IL230854A patent/IL230854A/en active IP Right Grant
-
2016
- 2016-01-21 US US15/003,368 patent/US9744252B2/en active Active
- 2016-11-21 JP JP2016225839A patent/JP2017075159A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX352546B (es) | Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo. | |
| JP2011105738A5 (es) | ||
| MY174025A (en) | Azole silane compound, surface treatment solution, surface treatment method, and use thereof | |
| IL181529A0 (en) | Diagnostic compounds | |
| MX356337B (es) | Anticuerpos contra csf-1r humano y sus usos. | |
| PH12013500365A1 (en) | Anti-infective agents and uses thereof | |
| EP2576578A4 (en) | POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF | |
| MX347515B (es) | Agentes que se unen al receptor encrespado y usos de los mismos. | |
| MY172806A (en) | New cyclohexylamine derivatives having ?2 adrenergic agonist and m3 muscarinic antagonist activities | |
| MX2013012793A (es) | Aminoacidos radiomarcados para imagen de diagnostico. | |
| BR112015004029A2 (pt) | Processo para preparação de teneligliptina, de um composto ou de sal ou hidrato do mesmo | |
| BR112015015368A2 (pt) | composições de absorventes de dejetos de animais revestidas debaixa densidade | |
| FR2959962B3 (fr) | Plaque pour la fabrication de chariots pour avion | |
| PH12016500683A1 (en) | Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines | |
| WO2012116196A3 (en) | Substituted lactosyl compounds and use thereof for cellular imaging and therapy | |
| AU2010332841A8 (en) | Prostate specific membrane antigen inhibitors | |
| PH12013501017A1 (en) | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system | |
| EP2924053A4 (en) | GLYCOSYLATED LINKER, COMPOUND WITH GLYCOSYLATED LINKER PART AND PHYSIOLOGICAL ACTIVE SUBSTANCE OR SALT AND METHOD FOR PRODUCING THIS COMPOUND OR THE SALT OF IT | |
| MX2013012795A (es) | Procursores novedosos de derivados de glutamato. | |
| MX356258B (es) | Agente de contraste para obtener imágenes de la perfusión miocárdica. | |
| IN2014DN06805A (es) | ||
| GB201110767D0 (en) | Infection imaging | |
| MX2013010781A (es) | Compuestos para usarse en formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. | |
| MX2011011191A (es) | Nuevas moléculas precursoras para marcadores de pet marcados con f-18. | |
| PH12014501760B1 (en) | Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |